| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |